Role of bacteria in experimental colitis

Bailliere's Best Practice and Research in Clinical Gastroenterology

Volumn 17, Issue 5, 2003, Pages 793-804

  Guarner, Francisco ^a   Malagelada, Juan R ^a  

^a HOSPITAL UNIVERSITARI VALL D HEBRON   (Spain)

Author keywords

Bacteria; Cytokines; Immunomodulation; Inflammation; Microflora; Mucosal barrier; Permeability; Prebiotic; Robiotic

Indexed keywords

ANTIBIOTIC AGENT; COLLAGEN; DEXTRAN SULFATE; IMIPENEM; INDOMETACIN; INTERLEUKIN 10; INTERLEUKIN 2 RECEPTOR; PROBIOTIC AGENT; TRANSFORMING GROWTH FACTOR BETA; TRANSFORMING GROWTH FACTOR BETA1; TRINITROBENZENESULFONIC ACID; TUMOR NECROSIS FACTOR ALPHA; VANCOMYCIN; INULIN; PREBIOTIC AGENT;

AEROBIC BACTERIUM; ANAEROBIC BACTERIUM; ANTIINFLAMMATORY ACTIVITY; ARTICLE; BACTERIAL COLONIZATION; BACTERIAL STRAIN; CHRONICITY; CLINICAL TRIAL; COLITIS; COLON MUCOSA; COMMENSALISM; CROHN DISEASE; CYTOKINE RELEASE; DISEASE CONTROL; DRUG EFFICACY; DRUG MECHANISM; ENTERITIS; EXPERIMENTAL MODEL; FIBROGENESIS; GENETIC ENGINEERING; GENETIC MANIPULATION; HUMAN; IMMUNE SYSTEM; INFECTION SENSITIVITY; INTESTINE FLORA; INTESTINE WALL; LACTOBACILLUS; MODULATION; MUCOSA INFLAMMATION; NONHUMAN; PERMEABILITY BARRIER; RISK ASSESSMENT; BIFIDOBACTERIUM; CELL COMMUNICATION; DIET SUPPLEMENTATION; INFLAMMATION; INTESTINE MUCOSA PERMEABILITY; REVIEW;

EID: 0346092491     PISSN: 15216918     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1521-6918(03)00068-4     Document Type: Review

References (56)

1. Thompson N.P. Montgomery S.M. Wadsworth M.E. Pounder R.E. Wakefield A.J. Early determinants of inflammatory bowel disease: use of two national longitudinal birth cohorts European Journal of Gastroenterology and Hepatology 12 2000 25-30
2. Bach J.F. The effect of infections on susceptibility to autoimmune and allergic diseases New England Journal of Medicine 347 2002 911-920
3. Gent A.E. Hellier M.D. Grace R.H. Swarbrick E.T. Coggon D. Inflammatory bowel disease and domestic hygiene in infancy Lancet 343 1994 766-767
4. Delco F. Sonnenberg A. Military history of patients with inflammatory bowel disease: An epidemiological study among U.S. veterans American Journal of Gastroenterology 93 1998 1457-1462
5. Reif S. Klein I. Lubin F. et al. Pre-illness dietary factors in inflammatory bowel disease Gut 40 1997 754-760
6. Corrao G. Tragnone A. Caprilli R. Risk of inflammatory bowel disease attributable to smoking, oral contraception and breastfeeding in Italy: a nationwide case-control study International Journal of Epidemiology 27 1998 397-404
7. Russel M.G. Engels L.G. Muris J.W. et al. 'Modern life' in the epidemiology of inflammatory bowel disease: a case-control study with special emphasis on nutritional factors European Journal of Gastroenterology and Hepatology 10 1998 243-249
8. Shoda R. Matsueda K. Yamato S. Umeda N. Epidemiologic analysis of Crohn's disease in Japan: increased dietary intake of n-6 polyunsaturated fatty acids and animal protein relates to the increased incidence of Crohn's disease in Japan American Journal of Clinical Nutrition 63 1996 741-745
9. Wurzelmann J.I. Lyles C.M. Sandler R.S. Childhood infections and the risk of inflammatory bowel disease Digestive Diseases Science 39 1994 555-560
10. Orholm M. Munkholm P. Langholz E. et al. Familial occurrence of inflammatory bowel disease New England Journal of Medicine 324 1991 84-88
11. Shanahan F. Inflammatory bowel disease: immunodiagnostics, immunotherapeutics, and ecotherapeutics Gastroenterology 120 2001 622-635
12. Brandtzaeg P. Halstensen T.S. Kett K. et al. Immunobiology and immuno-pathology of human gut mucosa: humoral immunity and intraepithelial lymphocytes Gastroenterology 97 1989 1562-1584
13. Pirzer U. Schönhaar A. Fleischer B. Hermann E. Meyer zum Büschenfelde K.H. Reactivity of infiltrating T lymphocytes with microbial antigens in Crohn's disease Lancet 338 1991 1238-1239
14. Macpherson A. Khoo U.Y. Forgacs I. Philpott-Howard J. Bjarnason I. Mucosal antibodies in inflammatory bowel disease are directed against intestinal bacteria Gut 38 1996 365-375
15. Morrissey P.J. Charrier K. Induction of wasting disease in SCID mice by the transfer of normal CD4+/CD45RBhi T cells and the regulation of this autoreactivity by CD4+/CD45RBlo T cells Research in Immunology 145 1994 357-362
16. Kent T.H. Cardelli R.M. Stamier F.W. Small intestinal ulcers and intestinal flora in rats given indomethacin American Journal of Pathology 34 1969 237-245
17. Yamada T. Deitch E. Specian R.D. et al. Mechanisms of acute and chronic intestinal inflammation induced by indomethacin Inflammation 17 1993 641-662
18. Okayasu I. Hatakeyama S. Yamada M. et al. A novel method in the induction of reliable experimental acute and chronic ulcerative colitis in mice Gastroenterology 98 1990 694-702
19. Videla S. Vilaseca J. Guarner F. et al. Role of intestinal microflora in chronic inflammation and ulceration of the rat colon Gut 35 1994 1090-1097
20. Taurog J.D. Richardson J.A. Croft J.T. et al. The germfree state prevents development of gut and joint inflammatory disease in HLA-B27 transgenic rats Journal of Experimental Medicine 180 1994 2359-2364
21. Sadlack B. Merz H. Schorle H. et al. Ulcerative colitis-like disease in mice with a disrupted interleukin-2 gene Cell 75 1993 253-261
22. Kühn R. Löhler J. Rennick D. Rajewski K. Müller W. Interleukin-10-deficient mice develop chronic enterocolitis Cell 75 1993 263-274
23. Umesaki Y. Setoyama H. Matsumoto S. Okada Y. Expansion of alpha beta T-cell receptor-bearing intestinal intraepithelial lymphocytes after microbial colonization in germ-free mice and its independence from thymus Immunology 79 1993 32-37
24. Falk P.G. Hooper L.V. Midtvedt T. Gordon J.I. Creating and maintaining the gastrointestinal ecosystem: what we know and need to know from gnotobiology Microbiology and Molecular Biology Review 62 1998 1157-1170
25. Morris G.P. Beck P.L. Herridge M.S. et al. Hapten-induced model of chronic inflammation and ulceration in the rat colon Gastroenterology 96 1989 795-803
26. Appleyard C.B. Wallace J.L. Reactivation of hapten-induced colitis and its prevention by anti-inflammatory drugs American Journal Physiology 269 1995 G119-G125
27. Videla S. Garcia-Lafuente A. Antolin M. et al. Antitumor necrosis factor therapy in rat chronic granulomatous colitis: critical dose-timing effects on outcome Journal Pharmacology and Experimental Therapeutics 287 1998 854-859
28. García-Lafuente A. Antolín M. Guarner F. et al. Incrimination of anaerobic bacteria in the induction of experimental colitis American Journal of Physiology 272 1997 G10-G11
29. Mourelle M. Salas A. Guarner F. et al. Stimulation of transforming growth factor-β1 by enteric bacteria in the pathogenesis of rat intestinal fibrosis Gastroenterology 114 1998 519-526
30. Madsen K.L. Malfair D. Gray D. et al. Interleukin-10 gene-deficient mice develop a primary intestinal permeability defect in response to enteric microflora Inflammatory Bowel Disease 5 1999 262-270
31. Kindon H. Pothoulakis C. Thim L. Devaney K. Podolsky D.K. Trefoil peptide protection of intestinal epithelial barrier function: cooperative interaction with mucin glycoprotein Gastroenterology 109 1995 516-523
32. Matsuo K. Ota H. Akamatsu T. Sugiyama A. Katsuyama T. Histochemistry of the surface mucous gel layer of the human colon Gut 40 1997 782-789
33. Lichtenberger L.M. The hydrophobic barrier properties of gastrointestinal mucus Annual Review of Physiology 57 1995 565-583
34. Lugea A. Salas A. Casalot J. Guarner F. Malagelada J.R. Surface hydrophobicity of the rat colonic mucosa is a defensive barrier against macromolecules and toxins Gut 46 2000 515-521
35. Goddard P.J. Kao Y.J. Lichtenberger L.M. Luminal surface hydrophobicity of canine gastric mucosa is dependent on a surface mucous gel Gastroenterology 98 1990 361-370
36. Kao Y.J. Goddard P.J. Lichtenberger L.M. Morphological effects of aspirin and prostaglandin on the canine gastric mucosal surface Gastroenterology 98 1990 592-606
37. Okayasu I. Hatakeyama S. Yamada M. et al. A novel method in the induction of reliable experimental acute and chronic ulcerative colitis in mice Gastroenterology 98 1990 694-702
38. García-Lafuente A. Antolín M. Guarner F. Crespo E. Malagelada J.R. Modulation of colonic barrier function by the composition of the commensal flora in the rat Gut 48 2001 503-507
39. Bjarnason I. Macpherson A. Hollander D. Intestinal permeability: an overview Gastroenterology 108 1995 1566-1581
40. Hilsden R.J. Meddings J.B. Sutherland L.R. Intestinal permeability changes in response to acetylsalicylic acid in relatives of patients with Crohn's disease Gastroenterology 110 1996 1395-1403
41. Wyatt J. Vogelsang H. Hübl W. Waldhöer T. Lochs H. Intestinal permeability and the prediction of relapse in Crohn's disease Lancet 341 1993 1437-1439
42. Guarner F. Schaafsma G. Probiotics International Journal Food Microbiology 39 1998 237-238
43. Gibson G.R. Roberfroid M.B. Dietary modulation of the human colonic microbiota: introducing the concept of prebiotics Journal of Nutrition 125 1995 1401-1412
44. Madsen K.L. Doyle J.S. Jewell L.D. Tavernini M.M. Fedorak R.N. Lactobacillus species prevents colitis in interleukin 10 gene-deficient mice Gastroenterology 116 1999 1107-1114
45. O'Mahony L. Feeney M. O'Halloran S. et al. Probiotic impact on microbial flora, inflammation and tumour development in IL-10 knockout mice Alimentary Pharmacology and Therapeutics 15 2001 1219-1225
46. Madsen K. Cornish A. Soper P. et al. Probiotic bacteria enhance murine and human intestinal epithelial barrier function Gastroenterology 121 2001 580-591
47. Schultz M. Veltkamp C. Dieleman L.A. et al. Lactobacillus plantarum 299 V in the treatment and prevention of spontaneous colitis in interleukin-10-deficient mice Inflammatory Bowel Disease 8 2002 71-80
48. Kennedy R.J. Hoper M. Deodhar K. Kirk S.J. Gardiner K.R. Probiotic therapy fails to improve gut permeability in a hapten model of colitis Scandinavian Journal of Gastroenterology 35 2000 1266-1271
49. Steidler L. Hans W. Schotte L. et al. Treatment of murine colitis by Lactococcus lactis secreting interleukin-10 Science 289 2000 1352-1355
50. Videla S. Vilaseca J. Antolín M. et al. Dietary inulin improves distal colitis induced by dextran sodium sulfate in the rat American Journal of Gastroenterology 96 2001 1486-1493
51. Kruis W. Schutz E. Fric P. et al. Double-blind comparison of an oral Escherichia coli preparation and mesalazine in maintaining remission of ulcerative colitis Alimentary Pharmacology and Therapeutics 11 1997 853-858
52. Rembacken B.J. Snelling A.M. Hawkey P.M. Chalmers D.M. Axon A.T. Non-pathogenic Escherichia coli versus mesalazine for the treatment of ulcerative colitis: a randomised trial Lancet 354 1999 635-639
53. Gionchetti P. Rizzello F. Venturi A. et al. Oral bacteriotherapy as maintenance treatment in patients with chronic pouchitis: a double-blind, placebo-controlled trial Gastroenterology 119 2000 305-309
54. Prantera C. Scribano M.L. Falasco G. Andreoli A. Luzi C. Ineffectiveness of probiotics in preventing recurrence after curative resection for Crohn's disease: a randomised controlled trial with Lactobacillus GG Gut 51 2002 405-409
55. Borruel N. Carol M. Casellas F. Increased mucosal TNFa production in Crohn's disease can be modulated in vitro by probiotic bacteria Gut 51 2002 659-664
56. Borruel N. Casellas F. Antolín M. et al. Effects of nonpathogenic bacteria on cytokine secretion by human intestinal mucosa American Journal of Gastroenterology 98 2003 865-870